B. Riley
http://www.brileyco.comB. Riley provides investment banking services to wide range of companies, as well as research and trading ideas to individual and institutional clients.
View Older Stories View More Recent Stories
-
The AZEK Company Inc. (AZEK) Prices 20M Share Common Offering at $40/Sh
-
Form 424B5 B. Riley Financial, Inc.
-
The AZEK® Company Announces Pricing of Public Offering of Class A Common Stock
-
Global Ship Lease (GSL) to Offer Common Stock
-
Global Ship Lease Announces Commencement of Public Offering of Class A Common Shares
-
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
-
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
-
Trinity Capital Inc. (TRIN) Announces Proposed 7.547M Share IPO Between $13.50-$15.50/Sh
-
Trinity Capital Inc. Announces Proposed Initial Public Offering
-
OTC Markets Group Welcomes Tuesday Morning to OTCQX
-
Form FWP B. Riley Financial, Inc. Filed by: B. Riley Financial, Inc.
-
Greenwich LifeSciences to Present at B. Riley Securities and BIO CEO & Investor Conferences
-
5 Top Penny Stocks To Watch During January's Biotech Boom
-
Edify Acquisition Corp. Announces Closing of Upsized $276 Million Initial Public Offering of Securities and Full Exercise of Overallotment Option
-
B. Riley Financial Announces Pricing of $200 Million Offering of Senior Notes Due 2028
-
NEUVOGEN Announces Participation at B. Riley Virtual Oncology Investor Conference
-
Celularity to Present at the B. Riley Securities Virtual Oncology Investor Conference
-
Form 8-K B. Riley Financial, Inc. For: Jan 20
-
FusionIQ Delivers Digital Investment Platform to Ultimus Fund Solutions' Clients
-
Axcelis to Participate in the B. Riley Securities' Vision Day
-
Form 424B5 B. Riley Financial, Inc.
-
B. Riley Financial Announces Offering of $100 Million Senior Notes Due 2028 and "BBB+" Rating from Egan-Jones
-
Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021
-
Actinium to Participate in a Fireside Chat at the B. Riley Oncology Investor Conference
-
Tiziana Life Sciences to Participate in a Fireside Chat at B. Riley Virtual Oncology Investor Conference on 21 January 2021 at 3 pm ET/8 pm GMT
-
Tiziana Life Sciences to Participate in a Fireside Chat at B. Riley Virtual Oncology Investor Conference on 21 January 2021 at 3 pm ET/8 pm GMT
-
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference
-
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference
-
Celcuity to Present at the B. Riley Oncology Investor Conference
-
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
-
Agenus to Participate in B. Riley Securities' Oncology Investor Conference
-
Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference
-
Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference
-
Puma Biotechnology to Present at the B. Riley Oncology Investor Conference
-
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
-
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
-
Compass Therapeutics to Participate in the B. Riley Securities Virtual Oncology Investor Conference
-
iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference
-
G2 Goldfields Announces Commencement of OTCQX Trading
-
Bed Bath & Beyond Inc. Completes Sale of Cost Plus World Market
-
Mosaic ImmunoEngineering Inc. Announces Upgrade to OTCQB Venture Market and Upcoming Presentation at the B. Riley Oncology Investor Conference
-
EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference
-
X4 Pharmaceuticals to Participate at the Virtual B. Riley Oncology Institutional Investor Conference
-
EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference
-
OTC Markets Group Welcomes G2 Goldfields Inc. to OTCQX
-
Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021
-
Purple Biotech to Present at the B. Riley Oncology Investor Conference
-
Purple Biotech to Present at the B. Riley Oncology Investor Conference
-
Monroe Capital Corporation Prices Offering of $130 Million 4.75% Notes Due 2026
-
Monroe Capital Corporation Prices Offering of $130 Million 4.75% Notes Due 2026

